Immune checkpoint inhibitor-associated ophthalmic adverse events: current understanding of its mechanisms, diagnosis, and management

Immune checkpoint inhibitor-associated ophthalmic adverse events: current understanding of its mechanisms, diagnosis, and management

Immune checkpoint inhibitors (ICIs) targeting cytotoxic T-lymphocyte antigen 4 and programmed cell death protein 1 receptor/ligand have revolutionized cancer treatment, achieving unprecedented efficacy in numerous malignancies. Despite the excellent therapeutic effects of ICIs, medications, such as...

Full description

Bibliographic Details
Main Authors: Yu-Wen Zhou, Qian Xu, Yan Wang, Ruo-Lan Xia, Ji-Yan Liu, Xue-Lei Ma
Format: Article
Language:English
Published: Press of International Journal of Ophthalmology (IJO PRESS) 2022-04-01
Series:International Journal of Ophthalmology
Subjects:
immune checkpoint inhibitor
ophthalmological adverse events
uveitis
neuro-ophthalmic toxicity
retinopathy
Online Access:http://ies.ijo.cn/en_publish/2022/4/20220419.pdf

Internet

http://ies.ijo.cn/en_publish/2022/4/20220419.pdf

Similar Items